RIBOLIFE-B 06938Hong Kong Stock Exchange

55.9003.04%( +1.650 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
RIBOLIFE-B (06938) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Suzhou Ribo Life Science Co
Market
HKEX Main Board
Listing Date
2026-01-09
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007DS6

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)174.15M82/112
Net Profit (Last FY)-326.07M95/125

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
梁子才 Executive Director
甘黎明 Executive Director
张鸿雁 Executive Director
戚飞 Executive Director
李东方 Executive Director
李宇辉 Executive Director
宇学峰 Executive Director
马朝松 Executive Director
王瑞平 Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-01-08.

About this page

This page shows RIBOLIFE-B (06938) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.